The company develops therapeutic endoscopy devices for minimally invasive treatment of obesity and metabolic disorders. These devices enable physicians to perform less invasive procedures within the gastrointestinal tract, offering patients advanced tools for therapeutic endoscopy treatments.
Funding
$1.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current endoscopic procedures for soft tissue apposition and closure in the GI tract often require incisions, leading to increased patient recovery time and potential complications. Existing tools may lack the precision and flexibility needed for minimally invasive therapeutic interventions within the gastrointestinal system.
Solution
Sotelix Endoscopy is developing a novel therapeutic endoscope designed to enable soft tissue plication and closure within the upper and lower GI tract without the need for incisions. This minimally invasive approach aims to improve patient outcomes and reduce recovery times. The endoscope is designed for procedures that depend on precise apposition or closure of tissue, offering physicians advanced tools for a range of therapeutic endoscopy treatments. The technology facilitates a variety of procedures, including endoscopic sleeve gastroplasty, transoral outlet reduction (TORe), fistula repair, perforation/leak repair, resection site closure, and LES augmentation for GERD.
Target Audience
The primary target audience includes gastroenterologists, therapeutic endoscopists, and surgeons specializing in minimally invasive GI procedures.
Features
- Novel endoscope design for incision-less soft tissue plication and closure
- Enhanced precision and control for complex GI procedures
- Compatibility with a range of therapeutic applications, including bariatric and reconstructive procedures